200 related articles for article (PubMed ID: 15857538)
1. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
4. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.
Dominguez TE; Mitchell M; Friess SH; Huh JW; Manno CS; Ravishankar C; Gaynor JW; Tabbutt S
Pediatr Crit Care Med; 2005 May; 6(3):348-51. PubMed ID: 15857537
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
7. Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
Girona E; Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Solís J; García-Sepulcre MF; Oliver-García I
South Med J; 2007 Jun; 100(6):601-4. PubMed ID: 17591314
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
10. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
17. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
[TBL] [Abstract][Full Text] [Related]
18. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
Veneri D; Franchini M
Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
[No Abstract] [Full Text] [Related]
20. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
